NEBIVOLOL HYDROCHLORIDE | A203828 | INDCHEMIE HEALTH SPECIALTIES PVT LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Forest Laboratories, Inc. et al v. Indchemie Health Specialties PVT. LTD. et al 1 patentANDA 203828, 203741nebivolol hydrochloride | N.D. Ill. | 2012-03-14 | Terminated 2013-12-19 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.1839
per ea
Lowest NADAC/Unit
$0.1042
per ea
Brand NDCs
0
Generic NDCs
9
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 67877039090NEBIVOLOL 20 MG TABLET | $0.1839 | EA | Generic | — | 2026-06-17 |
| 67877039030NEBIVOLOL 20 MG TABLET | $0.1839 | EA | Generic | — | 2026-06-17 |
| 67877039190NEBIVOLOL 10 MG TABLET | $0.1474 | EA | Generic | — | 2026-06-17 |
| 60687065221NEBIVOLOL 10 MG TABLET | $0.1474 | EA | Generic | — | 2026-06-17 |
| 67877039130NEBIVOLOL 10 MG TABLET | $0.1474 | EA | Generic | — | 2026-06-17 |
| 67877039330NEBIVOLOL 2.5 MG TABLET | $0.1217 | EA | Generic | — | 2026-06-17 |
Showing 6 of 9 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.